Evidence map›Paper›PMID 41072411›Full record

ArticleStem cell reports2025

The marketing of "stem cell" supplements on Amazon.com: Assessing alignment with regulatory frameworks in the United States and Canada.

Alessandro R Marcon, Marco Zenone, Vincenza Boniface, Sophie Sigfstead, Blake Murdoch, Timothy Caulfield

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Stem cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alessandro R MarconHealth Law Institute, Office 470, Faculty of Law, University of Alberta, Edmonton, AB T6G 2H5, Canada. Electronic address: marcon@ualberta.ca.
Marco ZenoneHealth Law Institute, Office 470, Faculty of Law, University of Alberta, Edmonton, AB T6G 2H5, Canada; Faculty of Health Sciences, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Vincenza BonifaceHealth Law Institute, Office 470, Faculty of Law, University of Alberta, Edmonton, AB T6G 2H5, Canada.
Sophie SigfsteadHealth Law Institute, Office 470, Faculty of Law, University of Alberta, Edmonton, AB T6G 2H5, Canada.
Blake MurdochHealth Law Institute, Office 470, Faculty of Law, University of Alberta, Edmonton, AB T6G 2H5, Canada.
Timothy CaulfieldHealth Law Institute, Office 470, Faculty of Law, University of Alberta, Edmonton, AB T6G 2H5, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The direct-to-consumer marketing of stem cell interventions now includes an emerging ecommerce marketplace of "stem cell" supplements. This research assessed the marketing of stem cell supplements on Amazon.com, evaluating how that marketing aligned or conflicted with regulatory frameworks in the United States and Canada. Given the results, new regulation strategies should be considered to offer greater transparency and consumer protection.

Indexed as

MarketingStem CellsCanadaHumansUnited States

Identifiers

PMID41072411
PMCPMC12790744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.